656257-69-1

Basic information

• Product Name: 4-Pyridinecarboxamide, 2-bromo-N-methoxy-N-methyl-
• CAS NO: 656257-69-1
• Molecular Formula: C8H9BrN2O2
• Molecular Weight: 245.076
• Mol File: 656257-69-1.mol
• Article Data: 18

Chemical Properties

• CAS DataBase Reference: 4-Pyridinecarboxamide, 2-bromo-N-methoxy-N-methyl-(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Pyridinecarboxamide, 2-bromo-N-methoxy-N-methyl-(656257-69-1)
• EPA Substance Registry System: 4-Pyridinecarboxamide, 2-bromo-N-methoxy-N-methyl-(656257-69-1)

Safety Data

• Hazardous Substances Data: 656257-69-1(Hazardous Substances Data)

Upstream product

• 6638-79-5 N,O-dimethylhydroxylamine*hydrochloride 
• 66572-56-3 2-bromoisonicotinic acid 
• 16645-06-0 N,N-dimethylhydroxylamine hydrochloride 

Downstream Products

• 111043-06-2 1-(2-bromo-4-pyridinyl)ethanone 
• 1187669-70-0 N-(3-methylphenyl)-4-[2-(4-methyl-1-piperazinyl)-4-pyridinyl]-1,3-thiazol-2-amine 
• 1187669-69-7 N-(3-methylphenyl)-4-[2-morpholin-4-yl-pyridin-4-yl]-1,3-thiazol-2-amine 
• 1187669-44-8 3-(4-{2-[(3-methylphenyl)amino]-1,3-thiazol-4-yl}-2-pyridinyl)-2-propyn-1-ol 
• 1187669-45-9 3-(4-{2-[(3-methylphenyl)amino]-1,3-thiazol-4-yl}-2-pyridinyl)-1-propanol 
• 1187669-42-6 4-(2-ethynyl-4-pyridinyl)-N-(3-methylphenyl)-1,3-thiazol-2-amine 
• 1187669-71-1 N,N-dimethyl-4-{2-[(3-methylphenyl)amino]-1,3-thiazol-4-yl}-pyridin-2-amine 
• 1187669-43-7 4-(2-ethyl-4-pyridinyl)-N-(3-methylphenyl)-1,3-thiazol-2-amine 
• 1187669-38-0 4-(2-bromo-4-pyridinyl)-N-(3-methylphenyl)-1,3-thiazol-2-amine 
• 1366407-37-5 1-[2-(4-fluorophenyl)pyridin-4-yl]ethanone 
• 1595292-44-6 2-[(diphenylmethylene)amino]-N-methoxy-N-methylisonicotinamide 

Relevant articles and documents

Aminopyridyloxypyrazole derivative and preparation method and application thereof

The invention relates to an aminopyridyloxypyrazole derivative and a preparation method and application thereof. The structure of the aminopyridyloxypyrazole derivative is shown as a formula (I). The invention provides a brand-new aminopyridyloxypyrazole derivative which has obvious effects of inhibiting TGF [beta] R1 (ALK5) kinase activity and treating cancer or fibrosis related diseases, and the preparation method of the derivative is simple and easy to operate.

FARNESOID X RECEPTOR AGONISTS AND USES THEREOF

Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.

MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF

Provided are novel compounds of Formula (I): and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions, associated with methyl modifying enzymes. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I), pharmaceutically acceptable salts thereof, and methods for their use in treating one or more diseases, disorders or conditions, associated with methyl modifying enzymes.